关注
Heying Duan
Heying Duan
在 stanford.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis
G Karanikas, M Schuetz, S Kontur, H Duan, S Kommata, R Schoen, ...
Thyroid 18 (1), 7-12, 2008
1892008
A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study
KP Willowson, M Tapner, QUEST Investigator Team, DL Bailey
European journal of nuclear medicine and molecular imaging 42, 1202-1222, 2015
1612015
PSMA-and GRPR-targeted PET: results from 50 patients with biochemically recurrent prostate cancer
L Baratto, H Song, H Duan, N Hatami, HP Bagshaw, M Buyyounouski, ...
Journal of Nuclear Medicine 62 (11), 1545-1549, 2021
592021
Prospective evaluation of 18F-DCFPyL PET/CT in biochemically recurrent prostate cancer in an academic center: a focus on disease localization and changes in management
H Song, C Harrison, H Duan, K Guja, N Hatami, BL Franc, F Moradi, ...
Journal of Nuclear Medicine 61 (4), 546-551, 2020
592020
Imaging the distribution of gastrin-releasing peptide receptors in cancer
L Baratto, H Duan, H Mäcke, A Iagaru
Journal of Nuclear Medicine 61 (6), 792-798, 2020
552020
11C-Methionine PET/CT Imaging of 99mTc-MIBI-SPECT/CT-Negative Patients With Primary Hyperparathyroidism and Previous Neck Surgery
T Traub-Weidinger, ME Mayerhoefer, O Koperek, M Mitterhauser, H Duan, ...
The Journal of Clinical Endocrinology & Metabolism 99 (11), 4199-4205, 2014
502014
The role of SPECT/CT in radioembolization of liver tumours
H Ahmadzadehfar, H Duan, AR Haug, S Walrand, M Hoffmann
European journal of nuclear medicine and molecular imaging 41, 115-124, 2014
492014
Comparison of 3 interpretation criteria for 68Ga-PSMA11 PET based on inter-and intrareader agreement
A Toriihara, T Nobashi, L Baratto, H Duan, F Moradi, S Park, N Hatami, ...
Journal of Nuclear Medicine 61 (4), 533-539, 2020
482020
Radiotheranostics-precision medicine in nuclear medicine and molecular imaging
H Duan, A Iagaru, CM Aparici
Nanotheranostics 6 (1), 103, 2022
392022
Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements
L Baratto, H Duan, R Laudicella, A Toriihara, N Hatami, V Ferri, A Iagaru
European Journal of Nuclear Medicine and Molecular Imaging 47, 115-122, 2020
342020
Quality of life aspects in the management of thyroid cancer
H Duan, E Gamper, A Becherer, M Hoffmann
Oral oncology 51 (6), S1-S5, 2015
342015
Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function
T Scherer, P Wolf, Y Winhofer, H Duan, E Einwallner, A Gessl, A Luger, ...
The Journal of Clinical Endocrinology & Metabolism 99 (11), E2341-E2346, 2014
332014
The effect of various β values on image quality and semiquantitative measurements in 68Ga-RM2 and 68Ga-PSMA-11 PET/MRI images reconstructed with a block sequential regularized …
L Baratto, H Duan, V Ferri, M Khalighi, A Iagaru
Clinical Nuclear Medicine 45 (7), 506-513, 2020
232020
T lymphocyte cytokine production patterns in Hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation
M Schuetz, H Duan, K Wahl, C Pirich, A Antoni, S Kommata, K Kletter, ...
Anticancer research 26 (6B), 4591-4596, 2006
212006
Correlation of 68Ga-RM2 PET with postsurgery histopathology findings in patients with newly diagnosed intermediate-or high-risk prostate cancer
H Duan, L Baratto, RE Fan, SJC Soerensen, T Liang, BI Chung, ...
Journal of Nuclear Medicine 63 (12), 1829-1835, 2022
182022
Oral ondansetron offers effective antidiarrheal activity for carcinoid syndrome refractory to somatostatin analogs
B Kiesewetter, H Duan, W Lamm, A Haug, P Riss, A Selberherr, ...
The oncologist 24 (2), 255-258, 2019
182019
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma
YJ Lee, NS van den Berg, H Duan, EC Azevedo, V Ferri, M Hom, ...
Clinical Cancer Research 28 (20), 4425-4434, 2022
152022
18F-FPPRGD2 PET/CT in patients with metastatic renal cell cancer
A Toriihara, H Duan, HM Thompson, S Park, N Hatami, L Baratto, AC Fan, ...
European Journal of Nuclear Medicine and Molecular Imaging 46, 1518-1523, 2019
152019
SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting
H Song, V Ferri, H Duan, CM Aparici, G Davidzon, BL Franc, F Moradi, ...
European Journal of Nuclear Medicine and Molecular Imaging 50 (8), 2250-2257, 2023
132023
Biodistribution of a Mitochondrial Metabolic Tracer, [18F]F-AraG, in Healthy Volunteers
J Levi, H Duan, S Yaghoubi, J Packiasamy, L Huynh, T Lam, F Shaikh, ...
Molecular Imaging 2022, 3667417, 2022
132022
系统目前无法执行此操作,请稍后再试。
文章 1–20